Clinical Trial Update: Statistical Basis for Hemochromatosis Screening

View source ↗

Summary

This clinical trials update explains the statistical basis for screening for hemochromatosis, sponsored by NHLBI, with the study listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemochromatosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Blood Disease, Hemochromatosis | Status: COMPLETED